Predictive factors for postherpetic neuralgia using ordered logistic regression analysis

Clinical Journal of Pain

Volumn 28, Issue 8, 2012, Pages 712-714

  Kanbayashi, Yuko ^a,b,c   Onishi, Keiko ^a,b   Fukazawa, Keita ^a,b   Okamoto, Kousuke ^c   Ueno, Hiroshi ^a,b   Takagi, Tatsuya ^c,d   Hosokawa, Toyoshi ^a,b  

^a University Hospital   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

advanced age; deep pain; ordered logistic regression analysis; postherpetic neuralgia; predictive factors

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BATH; CLINICAL FEATURE; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; HERPES ZOSTER; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTPATIENT; PAIN; POSTHERPETIC NEURALGIA; PREDICTION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HERPES ZOSTER; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84865648484     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e318243ee01     Document Type: Article

References (26)

1. Gilden D. Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia. J Intern Med. 2011;269:496-506.
2. Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002;18:350-354. (Pubitemid 35291575)
3. Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain. 1996;67:241-251. (Pubitemid 26375339)
4. Bowsher D. The management of postherpetic neuralgia. Postgrad Med J. 1997;73:623-629. (Pubitemid 27464457)
5. Johnson RW. Herpes zoster and postherpetic neuralgia. Expert Rev Vaccines. 2010;9:21-26.
6. McElhaney JE. Herpes zoster: a common disease that can have a devastating impact on patients' quality of life. Expert Rev Vaccines. 2010;9:27-30.
7. Johnson RW, McElhaney J. Postherpetic neuralgia in the elderly. J Int J Clin Pract. 2009;63:1386-1391.
8. Li Q, Chen N, Yang J, et al. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2009;2.
9. Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol. 2010;9:807-819.
10. Whitley RJ, Volpi A, McKendrick M, et al. Management of herpes zoster and post-herpetic neuralgia now and in the future. J Clin Virol. 2010;48:S20-S28.
11. Attal N, Cruccu G, Baron R, et al. European Federation of Neurological Societies. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17:1113-e88.
12. Doth AH, Hansson PT, Jensen MP, et al. The burden of neuropathic pain: a systematic review and meta-analysis of health utilities. Pain. 2010;149:338-344.
13. Jung BF, Johnson RW, Griffin DR, et al. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology. 2004;62:1545-1551. (Pubitemid 38608193)
14. Dworkin RH, Nagasako EM, Johnson RW, et al. Acute pain in herpes zoster: the famciclovir database project. Pain. 2001;94:113-119. (Pubitemid 32907563)
15. Johnson RW. Zoster-associated pain: what is known, who is at risk and how can it be managed? Herpes. 2007;14:30-34.
16. Kurokawa I, Kumano K, Murakawa K, Hyogo Prefectural PHN Study Group. Clinical correlates of prolonged pain in Japanese patients with acute herpes zoster. J Int Med Res. 2002;30:56-65. (Pubitemid 34618723)
17. Scott FT, Leedham-Green ME, Barrett-Muir WY, et al. A study of shingles and the development of posther-petic neuralgia in East London. J Med Virol. 2003;70: S24-S30. (Pubitemid 36368841)
18. Nithyanandam S, Dabir S, Stephen J, et al. Eruption severity and characteristics in herpes zoster ophthalmicus: correlation with visual outcome, ocular complications, and postherpetic neuralgia. Int J Dermatol. 2009;48:484-487.
19. Opstelten W, Zuithoff NP, van Essen GA, et al. Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: prospective prognostic study. Pain. 2007;132: S52-S59. (Pubitemid 350026201)
20. Parruti G, Tontodonati M, Rebuzzi C, et al. Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy. BMC Med. 2010;8:58.
21. Volpi A, Gatti A, Pica F, et al. Clinical and psychosocial correlates of post-herpetic neuralgia. J Med Virol. 2008;80: 1646-1652.
22. McKendrick MW, Ogan P, Care CC. A 9 year follow up of post herpetic neuralgia and predisposing factors in elderly patients following herpes zoster. J Infect. 2009;59:416-420.
23. Drolet M, Brisson M, Schmader K, et al. Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study. J Pain. 2010;11:1211-1221.
24. Mick G, Gallais JL, Simon F, et al. Burden of herpes zoster and postherpetic neuralgia: incidence, proportion, and associated costs in the French population aged 50 or over. Rev Epidemiol Sante Publique. 2010;58:393-401.
25. Kanai A, Wang G, Hoshi K, et al. Effects of intravenous prostaglandin E1 on pain and body temperature in patients with post-herpetic neuralgia. Pain Med. 2010;11: 609-616.
26. Han SS, Jung CH, Lee SC, et al. Does skin temperature difference as measured by infrared thermography within 6 months of acute herpes zoster infection correlate with pain level? Skin Res Technol. 2010;16:198-201.